Cargando…

SARS-CoV-2 neutralizing activity of polyphenols in a special green tea extract preparation

BACKGROUND: The COVID-19 pandemic will continue to threaten our health care systems in the next years. In addition to vaccination there is a need for effective tools for prevention and treatment. Products from natural sources, like standardized plant extracts offer a wide range of antiviral effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Kicker, Eva, Tittel, Gerolf, Schaller, Tanja, Pferschy-Wenzig, Eva-Maria, Zatloukal, Kurt, Bauer, Rudolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier GmbH. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801126/
https://www.ncbi.nlm.nih.gov/pubmed/35144138
http://dx.doi.org/10.1016/j.phymed.2022.153970
_version_ 1784642386437079040
author Kicker, Eva
Tittel, Gerolf
Schaller, Tanja
Pferschy-Wenzig, Eva-Maria
Zatloukal, Kurt
Bauer, Rudolf
author_facet Kicker, Eva
Tittel, Gerolf
Schaller, Tanja
Pferschy-Wenzig, Eva-Maria
Zatloukal, Kurt
Bauer, Rudolf
author_sort Kicker, Eva
collection PubMed
description BACKGROUND: The COVID-19 pandemic will continue to threaten our health care systems in the next years. In addition to vaccination there is a need for effective tools for prevention and treatment. Products from natural sources, like standardized plant extracts offer a wide range of antiviral effects and possible applications. PURPOSE: The aim of this study was to investigate, whether a sorbitol/lecithin-based throat spray containing concentrated green tea extract (sGTE) interacts with SARS-CoV-2 viral particles and additionally is capable to block the virus replication. STUDY DESIGN AND METHODS: The antiviral effect was studied in a VeroE6 cell culture model, including concentration/effect correlations and the biological mechanism of virus blockade, using the Wuhan type of SARS CoV-2 as well as its beta- and delta-mutations. In addition, the qualitative and quantitative tannin profile present on the oral mucosa after spray application has been investigated by LC-MS/MS and HPLC-DAD analyses of (-)-epigallocatechin-3-O-gallate (EGCG) and related catechin derivatives. RESULTS: The findings of this study demonstrate, that sGTE has strong neutralizing activity on SARS-CoV-2 resulting in an up to 6,3E+04-fold reduction of infectivity independent from the strain. The type of interaction of sGTE with surface proteins seems to be direct and non-specific concerning the viral surface protein structures and resembles the general non-specific activity of polyphenols. By HPLC-DAD analysis, eight catechins were identified in sGTE, with EGCG and (-)-epicatechin-3-O-gallate as the most abundant ones. The total content of catechin derivatives, calculated as catechin, was 76 g/100 g. LC-MS/MS and HPLC-DAD analyses of throat swabs after application of a sGTE spray have shown that the concentrations of green tea tannins in the pharyngeal mucosa are higher than the effective dose found in the in vitro studies with SARS-CoV-2, even 1 h after the last application. CONCLUSION: The findings of this study suggest that sGTE has strong neutralizing activity on SARS-CoV-2 independent from the strain (Wuhan strain, beta- or delta-variants). sGTE might be relevant for reduction of corresponding viral infections when periodically applied to mouth and throat.
format Online
Article
Text
id pubmed-8801126
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Authors. Published by Elsevier GmbH.
record_format MEDLINE/PubMed
spelling pubmed-88011262022-01-31 SARS-CoV-2 neutralizing activity of polyphenols in a special green tea extract preparation Kicker, Eva Tittel, Gerolf Schaller, Tanja Pferschy-Wenzig, Eva-Maria Zatloukal, Kurt Bauer, Rudolf Phytomedicine Original Article BACKGROUND: The COVID-19 pandemic will continue to threaten our health care systems in the next years. In addition to vaccination there is a need for effective tools for prevention and treatment. Products from natural sources, like standardized plant extracts offer a wide range of antiviral effects and possible applications. PURPOSE: The aim of this study was to investigate, whether a sorbitol/lecithin-based throat spray containing concentrated green tea extract (sGTE) interacts with SARS-CoV-2 viral particles and additionally is capable to block the virus replication. STUDY DESIGN AND METHODS: The antiviral effect was studied in a VeroE6 cell culture model, including concentration/effect correlations and the biological mechanism of virus blockade, using the Wuhan type of SARS CoV-2 as well as its beta- and delta-mutations. In addition, the qualitative and quantitative tannin profile present on the oral mucosa after spray application has been investigated by LC-MS/MS and HPLC-DAD analyses of (-)-epigallocatechin-3-O-gallate (EGCG) and related catechin derivatives. RESULTS: The findings of this study demonstrate, that sGTE has strong neutralizing activity on SARS-CoV-2 resulting in an up to 6,3E+04-fold reduction of infectivity independent from the strain. The type of interaction of sGTE with surface proteins seems to be direct and non-specific concerning the viral surface protein structures and resembles the general non-specific activity of polyphenols. By HPLC-DAD analysis, eight catechins were identified in sGTE, with EGCG and (-)-epicatechin-3-O-gallate as the most abundant ones. The total content of catechin derivatives, calculated as catechin, was 76 g/100 g. LC-MS/MS and HPLC-DAD analyses of throat swabs after application of a sGTE spray have shown that the concentrations of green tea tannins in the pharyngeal mucosa are higher than the effective dose found in the in vitro studies with SARS-CoV-2, even 1 h after the last application. CONCLUSION: The findings of this study suggest that sGTE has strong neutralizing activity on SARS-CoV-2 independent from the strain (Wuhan strain, beta- or delta-variants). sGTE might be relevant for reduction of corresponding viral infections when periodically applied to mouth and throat. The Authors. Published by Elsevier GmbH. 2022-04 2022-01-30 /pmc/articles/PMC8801126/ /pubmed/35144138 http://dx.doi.org/10.1016/j.phymed.2022.153970 Text en © 2022 The Authors. Published by Elsevier GmbH. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Article
Kicker, Eva
Tittel, Gerolf
Schaller, Tanja
Pferschy-Wenzig, Eva-Maria
Zatloukal, Kurt
Bauer, Rudolf
SARS-CoV-2 neutralizing activity of polyphenols in a special green tea extract preparation
title SARS-CoV-2 neutralizing activity of polyphenols in a special green tea extract preparation
title_full SARS-CoV-2 neutralizing activity of polyphenols in a special green tea extract preparation
title_fullStr SARS-CoV-2 neutralizing activity of polyphenols in a special green tea extract preparation
title_full_unstemmed SARS-CoV-2 neutralizing activity of polyphenols in a special green tea extract preparation
title_short SARS-CoV-2 neutralizing activity of polyphenols in a special green tea extract preparation
title_sort sars-cov-2 neutralizing activity of polyphenols in a special green tea extract preparation
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801126/
https://www.ncbi.nlm.nih.gov/pubmed/35144138
http://dx.doi.org/10.1016/j.phymed.2022.153970
work_keys_str_mv AT kickereva sarscov2neutralizingactivityofpolyphenolsinaspecialgreenteaextractpreparation
AT tittelgerolf sarscov2neutralizingactivityofpolyphenolsinaspecialgreenteaextractpreparation
AT schallertanja sarscov2neutralizingactivityofpolyphenolsinaspecialgreenteaextractpreparation
AT pferschywenzigevamaria sarscov2neutralizingactivityofpolyphenolsinaspecialgreenteaextractpreparation
AT zatloukalkurt sarscov2neutralizingactivityofpolyphenolsinaspecialgreenteaextractpreparation
AT bauerrudolf sarscov2neutralizingactivityofpolyphenolsinaspecialgreenteaextractpreparation